Drug regimens. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy1

Antilymphocyte Serum

Organisms5

Mycobacterium tuberculosis HIV-1 Helicobacter pylori Transplantation Chimera HIV

Diseases38

HIV Infections Tuberculosis, Multidrug-Resistant Tuberculosis, Pulmonary Tuberculosis Malaria Recurrence Disease Models, Animal Hypertension Neutropenia Lymphoma, Non-Hodgkin Nausea Vomiting Lung Neoplasms Breast Neoplasms Neoplasm Metastasis Leukopenia Graft vs Host Disease Hodgkin Disease Neoplasm Recurrence, Local Neoplasms Disease Progression Hematologic Diseases Thrombocytopenia Colorectal Neoplasms Acute Disease Adenocarcinoma Hematologic Neoplasms Multiple Myeloma Helicobacter Infections Precursor Cell Lymphoblastic Leukemia-Lymphoma Carcinoma, Non-Small-Cell Lung Fever Leukemia Ovarian Neoplasms Carcinoma, Small Cell Leukemia, Myeloid, Acute Stomatitis Body Weight

Chemicals and Drugs125

Antitubercular Agents Anti-HIV Agents Pyrazinamide Drug Combinations Ethambutol Isoniazid Rifampin Atovaquone Antimalarials Anti-Retroviral Agents Nevirapine HIV Protease Inhibitors Pyrimethamine Immunosuppressive Agents Reverse Transcriptase Inhibitors Cyclophosphamide Vincristine Anti-Bacterial Agents Sulfadoxine Doxorubicin Antiprotozoal Agents Antihypertensive Agents Chloroquine Antineoplastic Agents Fluorouracil Cisplatin Etoposide Prednisone Methotrexate Deoxycytidine Leucovorin Vinblastine Cytarabine Busulfan Benzoxazines Paclitaxel Vidarabine Organoplatinum Compounds Taxoids Ifosfamide Bleomycin Ritonavir Carboplatin Epirubicin Amoxicillin Camptothecin Antineoplastic Agents, Alkylating Melphalan Clarithromycin Antimetabolites, Antineoplastic Procarbazine Dacarbazine Stavudine Antibodies, Monoclonal, Humanized Metronidazole Organophosphonates Antibodies, Monoclonal Lopinavir Bismuth Antineoplastic Agents, Phytogenic Dexamethasone Antibiotics, Antitubercular Oxazines Mitoxantrone Granulocyte Colony-Stimulating Factor Prednisolone Anti-Ulcer Agents Antibodies, Monoclonal, Murine-Derived Lamivudine Anthracyclines Carmustine Anti-Infective Agents Mycophenolic Acid Zidovudine Dideoxynucleosides Ofloxacin Tacrolimus Omeprazole Pyrimidinones Cyclosporine Myeloablative Agonists Artemisinins Aza Compounds Quinolines Azithromycin Antiemetics Adenine Doxycycline Mechlorethamine Antilymphocyte Serum Thiotepa Didanosine Fluorenes Ondansetron Nelfinavir Idarubicin Gentamicins Levofloxacin Vindesine Penicillins 2-Pyridinylmethylsulfinylbenzimidazoles Tegafur Ranitidine Mesna Lomustine Amikacin Antiviral Agents Recombinant Proteins Pyrazines Asparaginase Rifabutin Interferon-alpha Insulin, Long-Acting Diarylquinolines Boronic Acids Methylprednisolone Mitomycin Topotecan Penicillin G Procaine Saquinavir Furazolidone Antibiotics, Antineoplastic Hypoglycemic Agents Mefloquine RNA, Viral

Analytical, Diagnostic and Therapeutic Techniques and Equipment65

Drug Therapy, Combination Treatment Outcome Drug Therapy Drug Administration Schedule Antineoplastic Combined Chemotherapy Protocols Polypharmacy Viral Load Antiretroviral Therapy, Highly Active Treatment Failure Clinical Trials as Topic Retrospective Studies CD4 Lymphocyte Count Prospective Studies Double-Blind Method Follow-Up Studies Randomized Controlled Trials as Topic Microbial Sensitivity Tests Kidney Transplantation Disease Models, Animal Cohort Studies Risk Factors Combined Modality Therapy Survival Analysis Administration, Oral Infusions, Intravenous Disease-Free Survival Transplantation Conditioning Remission Induction Salvage Therapy Survival Rate Hematopoietic Stem Cell Transplantation Transplantation, Autologous Whole-Body Irradiation Transplantation, Homologous Area Under Curve Prognosis Bone Marrow Transplantation Chemotherapy, Adjuvant Neoplasm Staging Injections, Intravenous Drug Evaluation Pilot Projects Random Allocation Immunization, Secondary Injections, Intramuscular Kaplan-Meier Estimate Neoadjuvant Therapy Cross-Over Studies Maximum Tolerated Dose Injections, Subcutaneous Feasibility Studies Drug Monitoring Clinical Trials, Phase II as Topic Drug Dosage Calculations Clinical Trials, Phase III as Topic Immunosuppression Drug Substitution Multivariate Analysis Hematopoietic Stem Cell Mobilization Colony Count, Microbial Actuarial Analysis Peripheral Blood Stem Cell Transplantation Antibiotic Prophylaxis Body Weight Stem Cell Transplantation

Psychiatry and Psychology2

Patient Compliance Medication Adherence

Phenomena and Processes17

Drug Resistance, Viral Viral Load Time Factors Dose-Response Relationship, Drug Drug Resistance CD4 Lymphocyte Count Drug Synergism Drug Interactions Graft Rejection Pregnancy Area Under Curve Graft Survival Half-Life Maximum Tolerated Dose Drug Resistance, Neoplasm Drug Resistance, Multiple, Viral Body Weight

Anthropology, Education, Sociology and Social Phenomena1

Information Science1

Named Groups1

Infant, Newborn

Health Care29

Treatment Outcome Patient Compliance Treatment Failure Clinical Trials as Topic Retrospective Studies Infectious Disease Transmission, Vertical Medication Adherence Prospective Studies Double-Blind Method Follow-Up Studies Randomized Controlled Trials as Topic Cohort Studies Risk Factors Age Factors Survival Analysis Disease-Free Survival Survival Rate Area Under Curve Pilot Projects Random Allocation Kaplan-Meier Estimate Cross-Over Studies Feasibility Studies Clinical Trials, Phase II as Topic Clinical Trials, Phase III as Topic Drug Substitution Multivariate Analysis Actuarial Analysis Cost-Benefit Analysis

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Drug Therapy, Combination Antitubercular Agents Treatment Outcome Anti-HIV Agents Drug Therapy Drug Administration Schedule Pyrazinamide Patient Compliance Drug Combinations HIV Infections Ethambutol Isoniazid Rifampin Atovaquone Antineoplastic Combined Chemotherapy Protocols Tuberculosis, Multidrug-Resistant Antimalarials Drug Resistance, Viral Polypharmacy Mycobacterium tuberculosis Anti-Retroviral Agents HIV-1 Viral Load Tuberculosis, Pulmonary Nevirapine HIV Protease Inhibitors Pyrimethamine Antiretroviral Therapy, Highly Active Immunosuppressive Agents Time Factors Reverse Transcriptase Inhibitors Cyclophosphamide Vincristine Tuberculosis Treatment Failure Anti-Bacterial Agents Clinical Trials as Topic Sulfadoxine Travel Doxorubicin Retrospective Studies Antiprotozoal Agents Dose-Response Relationship, Drug Drug Resistance Malaria Infectious Disease Transmission, Vertical Antihypertensive Agents CD4 Lymphocyte Count Chloroquine Recurrence Medication Adherence Drug Synergism Prospective Studies Antineoplastic Agents Drug Interactions Double-Blind Method Follow-Up Studies Randomized Controlled Trials as Topic Microbial Sensitivity Tests Graft Rejection Kidney Transplantation United States Pregnancy Disease Models, Animal Cohort Studies Risk Factors Infant, Newborn Hypertension Fluorouracil Age Factors Cisplatin Combined Modality Therapy Etoposide Survival Analysis Administration, Oral Infusions, Intravenous Disease-Free Survival Prednisone Transplantation Conditioning Methotrexate Remission Induction Salvage Therapy Survival Rate Deoxycytidine Leucovorin Vinblastine Cytarabine Busulfan Benzoxazines Hematopoietic Stem Cell Transplantation Paclitaxel Vidarabine Organoplatinum Compounds Taxoids Ifosfamide Neutropenia Bleomycin Ritonavir Carboplatin Lymphoma, Non-Hodgkin

No FAQ available that match "drug regimens"